Epidermal growth factor counteracts the insulin induced expression of glucokinase in hepatocytes.
Beresford
G W
GW
Department of Medicine, University of Newcastle upon Tyne.
Agius
L
L
D000818:Animals; D002478:Cells, Cultured; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D015870:Gene Expression / Q000187:drug effects*; D005934:Glucagon / Q000494:pharmacology; D005941:Glucokinase / Q000096:biosynthesis*; D007328:Insulin / Q000494:pharmacology*; D007329:Insulin Antagonists / Q000494:pharmacology*; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D012333:RNA, Messenger / Q000096:biosynthesis / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013997:Time Factors
D007328:Insulin; D007329:Insulin Antagonists; D012333:RNA, Messenger; D004815:Epidermal Growth Factor; D005934:Glucagon; D005941:Glucokinase; D013755:Tetradecanoylphorbol Acetate